You just read:

Neurocrine Announces Data on the Real-World Patient Impact of TD from the RE-KINECT Study to be Presented at the 2017 Annual Psych Congress

News provided by

Neurocrine Biosciences, Inc.

Sep 15, 2017, 09:25 ET